Russett, your DMSO argument doesn't make sense.
Firstly,
since DMSO is the carrier molecule, what evidence do you have that it builds up in the skin or damages epidemal cells?
Surely this carrier molecule would pass right through the skin (via tubules) to the arthritic site.
Secondly,
so what if an elderly person's skin regenerates more slowly than a young buck's skin.
IT STILL REGENERATES!
Your argument is suggesting that chronic use of Pennsaid is bad for the skin. If the skin regenerates, then chronic use is a non-issue!
Thirdly,
<<< You want to talk about DMSO's potential reactions in skin cells, why the shareprice of DMX is so low, why Pennsaid's sales suck, why we still don't have results from the WF10 trials, why the president sold her shares and refuses to talk about it? >>>
I have no desire whatsoever to talk about all that crap.
Where did you pull that idea from?
Since you mentioned it though, the share price hit my $1.99 buy trigger. I'm back in and quite happy to see it at $2.20 again. I'm up 10% so far and my $2.90-ish standing sell order is already active.
Lastly,
<<< I really liked your thread Nazi comment/quip,...I agree he resembles that (gggggggggg) >>>
That doesn't make us buddies.
S&P |
